Townsquare Capital LLC Increases Position in Balchem Co. (NASDAQ:BCPC)

Townsquare Capital LLC lifted its holdings in shares of Balchem Co. (NASDAQ:BCPC - Free Report) by 18.3% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 18,101 shares of the basic materials company's stock after purchasing an additional 2,801 shares during the period. Townsquare Capital LLC owned 0.06% of Balchem worth $2,950,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in the business. Covestor Ltd boosted its position in shares of Balchem by 93.8% during the 4th quarter. Covestor Ltd now owns 157 shares of the basic materials company's stock worth $26,000 after purchasing an additional 76 shares in the last quarter. Invesco Ltd. boosted its stake in Balchem by 21.2% during the 4th quarter. Invesco Ltd. now owns 228,933 shares of the basic materials company's stock valued at $37,315,000 after purchasing an additional 40,099 shares during the last quarter. Bank of Montreal Can raised its stake in shares of Balchem by 1.9% in the fourth quarter. Bank of Montreal Can now owns 29,024 shares of the basic materials company's stock worth $4,731,000 after purchasing an additional 536 shares during the last quarter. FMR LLC lifted its position in shares of Balchem by 16.0% during the fourth quarter. FMR LLC now owns 576,994 shares of the basic materials company's stock valued at $94,047,000 after purchasing an additional 79,499 shares in the last quarter. Finally, Federated Hermes Inc. bought a new position in shares of Balchem during the 4th quarter worth approximately $33,000. Institutional investors and hedge funds own 87.91% of the company's stock.

Balchem Trading Down 1.2 %

Balchem stock traded down $1.86 during trading hours on Monday, reaching $159.64. The stock had a trading volume of 8,311 shares, compared to its average volume of 129,159. The company has a fifty day simple moving average of $164.84 and a 200-day simple moving average of $167.65. Balchem Co. has a 52 week low of $137.69 and a 52 week high of $186.03. The stock has a market cap of $5.19 billion, a PE ratio of 40.62, a PEG ratio of 4.41 and a beta of 0.75. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.99 and a quick ratio of 1.16.

Balchem (NASDAQ:BCPC - Get Free Report) last released its quarterly earnings results on Friday, February 21st. The basic materials company reported $1.03 EPS for the quarter, missing analysts' consensus estimates of $1.11 by ($0.08). The business had revenue of $240.00 million for the quarter, compared to the consensus estimate of $239.96 million. Balchem had a net margin of 13.47% and a return on equity of 11.37%. Analysts forecast that Balchem Co. will post 4.64 EPS for the current fiscal year.

Analyst Ratings Changes

A number of research analysts have recently weighed in on the stock. Sidoti raised shares of Balchem to a "hold" rating in a research report on Tuesday, February 25th. StockNews.com cut shares of Balchem from a "buy" rating to a "hold" rating in a research note on Tuesday, February 25th. Finally, HC Wainwright reissued a "buy" rating and set a $190.00 price objective on shares of Balchem in a report on Monday, February 24th.

Balchem Company Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.